The high court is expected to drop its opinion deciding two conflicting federal rulings questioning FDA approval of mifepristone, a drug commonly used for abortions. Reset digs into when justices will drop that decision and how it could impact abortion access across the country with Steven Schwinn, Professor at University of Illinois Chicago Law School.